GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Total Long-Term Liabilities

Bavarian Nordic A/S (Bavarian Nordic A/S) Total Long-Term Liabilities

: $179 Mil (As of Dec. 2023)
View and export this data going back to 2013. Start your Free Trial

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Bavarian Nordic A/S's Total Long-Term Liabilities for the quarter that ended in Dec. 2023 was $179 Mil.


Bavarian Nordic A/S Total Long-Term Liabilities Historical Data

The historical data trend for Bavarian Nordic A/S's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 466.23 476.24 426.39 420.61 179.29

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Long-Term Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 420.61 326.61 346.49 168.34 179.29

Bavarian Nordic A/S Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


Bavarian Nordic A/S Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines

From GuruFocus

Bavarian Nordic A/S - Special Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2019 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S - Special Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024